{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T22:56:29Z","timestamp":1781564189845,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.pcad.2022.05.007","type":"journal-article","created":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T01:14:39Z","timestamp":1654391679000},"page":"78-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM) of aortic bioprostheses: An imaging finding or a complication?"],"prefix":"10.1016","volume":"72","author":[{"given":"Yousif","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Makkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Sondergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2022.05.007_bb0005","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/S0140-6736(15)60290-2","article-title":"PARTNER trial investigators. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Kapadia","year":"2015","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.pcad.2022.05.007_bb0010","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","article-title":"5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Mack","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.pcad.2022.05.007_bb0015","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1910555","article-title":"Five-year outcomes of transcatheter or surgical aortic-valve replacement","volume":"382","author":"Makkar","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.05.007_bb0020","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2020.12.052","article-title":"Outcomes 2 years after transcatheter aortic valve replacement in patients at low surgical risk","volume":"77","author":"Leon","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2022.05.007_bb0025","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.jacc.2018.08.2146","article-title":"5-year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients","volume":"72","author":"Gleason","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2022.05.007_bb0030","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis","volume":"370","author":"Adams","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.05.007_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcin.2019.10.043","article-title":"Complete 2-year results confirm Bayesian analysis of the SURTAVI Trial","volume":"13","author":"Van Mieghem","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2022.05.007_bb0040","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.05.007_bb0045","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1093\/eurheartj\/eht316","article-title":"Cusp thrombosis after transcatheter aortic valve replacement detected by computed tomography and echocardiography","volume":"34","author":"Pache","year":"2013","journal-title":"Eur Heart J Oxford Academic"},{"key":"10.1016\/j.pcad.2022.05.007_bb0050","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1509233","article-title":"Possible subclinical leaflet thrombosis in bioprosthetic aortic valves","volume":"373","author":"Makkar","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.05.007_bb0055","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(17)30757-2","article-title":"Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study","volume":"389","author":"Chakravarty","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.pcad.2022.05.007_bb0060","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.jacc.2020.04.043","article-title":"Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves","volume":"75","author":"Makkar","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2022.05.007_bb0065","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.jacc.2020.03.022","article-title":"Bioprosthetic aortic valve leaflet thickening in the evolut low risk sub-study","volume":"75","author":"Blanke","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2022.05.007_bb0070","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.echo.2009.07.013","volume":"22","author":"Zoghbi","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.pcad.2022.05.007_bb0075","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/ejcts\/ezz099","article-title":"Incidence, predictors and cerebrovascular consequences of leaflet thrombosis after transcatheter aortic valve implantation: a systematic review and meta-analysis","volume":"56","author":"D\u2019Ascenzo","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.pcad.2022.05.007_bb0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.amjcard.2020.07.018","article-title":"Meta-analysis of incidence, predictors and consequences of clinical and subclinical bioprosthetic leaflet thrombosis after Transcatheter aortic valve implantation","volume":"132","author":"Sannino","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2022.05.007_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005251","article-title":"Hypo-attenuated leaflet thickening and reduced leaflet motion in sutureless bioprosthetic aortic valves","volume":"6","author":"Dal\u00e9n","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2022.05.007_bb0090","first-page":"e1067","article-title":"Subclinical leaflet thickening and stent frame geometry in self-expanding transcatheter heart valves","volume":"13","author":"Fuchs","year":"2017","journal-title":"EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol"},{"key":"10.1016\/j.pcad.2022.05.007_bb0095","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.athoracsur.2013.11.009","article-title":"The effects of transcatheter valve crimping on pericardial leaflets","volume":"97","author":"Alavi","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.pcad.2022.05.007_bb0100","article-title":"The role of flow stasis in transcatheter aortic valve leaflet thrombosis","author":"Trusty","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pcad.2022.05.007_bb0105","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.jacc.2017.02.051","article-title":"Bioprosthetic valve thrombosis","volume":"69","author":"Puri","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2022.05.007_bb0110","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.jacc.2015.09.022","article-title":"Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors","volume":"66","author":"Egbe","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2022.05.007_bb0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcmg.2017.02.005","article-title":"Systematic CT methodology for the evaluation of subclinical leaflet thrombosis","volume":"10","author":"Jilaihawi","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2022.05.007_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmg.2016.11.005","article-title":"Incidence, predictors, and mid-term outcomes of possible leaflet thrombosis after TAVR","volume":"10","author":"Yanagisawa","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2022.05.007_bb0125","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/eurheartj\/ehx369","article-title":"Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves","volume":"38","author":"Sondergaard","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2022.05.007_bb0130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A controlled trial of rivaroxaban after Transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.05.007_bb0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1911426","article-title":"GALILEO-4D Investigators. Reduced leaflet motion after Transcatheter aortic-valve replacement","volume":"382","author":"De Backer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.05.007_bb0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.carrev.2021.01.016","article-title":"Single versus dual antiplatelet therapy after transcatheter aortic valve replacement: a meta-analysis of randomized clinical trials","volume":"34","author":"Ahmad","year":"2021","journal-title":"Cardiovasc Revascularization Med"},{"key":"10.1016\/j.pcad.2022.05.007_bb0145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2018.03.008","article-title":"Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: the randomized ATLANTIS trial","volume":"200","author":"Collet","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2022.05.007_bb0150","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062022000585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062022000585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:20:45Z","timestamp":1758500445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062022000585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":30,"alternative-id":["S0033062022000585"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2022.05.007","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM) of aortic bioprostheses: An imaging finding or a complication?","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2022.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}